1. Stocks
  2. Dr. Lal Pathlabs Ltd.
  3. Swot
swot-logo

Dr. Lal Pathlabs Ltd. SWOT Analysis: Strengths, Weakness, Opportunity, and Threats

Dr. Lal Pathlabs Ltd. has 22 Strengths, 5 Weaknesses, 1 Opportunities and 1 Threats. The SWOT product gives you a quick x-ray of a stock's outlook and potential

Add SWOT widget to your site/app

Companies with no Debt

Benjamin Graham Value Screen

Strong Momentum: Price above short, medium and long term moving averages

Relative Outperformance versus Industry over 1 Month

Relative Outperformance versus Industry over 1 Year

Expensive Performers (DVM)

Annual Profit Growth higher than Sector Profit Growth

Stocks gaining versus previous close, open price and RSI

Dividend yield greater than sector dividend yield

High Momentum Scores (Technical Scores greater than 50)

Relative Outperformance versus Industry over 1 Month

Overbought by Money Flow Index (MFI)

Growth in Net Profit with increasing Profit Margin (QoQ)

Strong cash generating ability from core business - Improving Cash Flow from operation for last 2 years

Annual Net Profits improving for last 2 years

Companies with Zero Promoter Pledge

Negative to Positive growth in Sales and Profit with Strong Price momentum

RSI indicating price strength

Top Gainers

Volume Shockers

Stocks near 52 Week High with Significant Volumes

Stocks Outperforming their Industry Price Change in the Quarter

Companies with growing costs YoY for long term projects

PE higher than Industry PE

PEG greater than Industry PEG

High PE (PE > 40)

Stocks with Expensive Valuations according to the Trendlyne Valuation Score

MFs increased their shareholding last quarter

Insiders sold stocks

Big Changes up or down in FII holding

Expensive Performers (DVM)

Average Financial Performers - Stocks with Medium Trendlyne Durability Score versus Benchmarks

Average Bullish Trend - Stocks with Medium Trendlyne Momentum Score versus Benchmarks